Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3546 |
|
| Actual shortage: | 240 (7%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3292 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LEVETIRACETAM | 250MG | TABLET | Resolved | 2018-10-19 | 2019-01-10 | 64938 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2018-12-12 | 2018-12-21 | 69307 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2019-02-24 | 2019-04-26 | 76720 |
| APO-LEVETIRACETAM | 500MG | TABLET | Resolved | 2019-03-13 | 2019-05-03 | 78526 |
| APO-LEVETIRACETAM | 250MG | TABLET | Resolved | 2019-03-20 | 2019-04-26 | 79045 |
| APO-LEVETIRACETAM | 500MG | TABLET | Resolved | 2019-05-22 | 2019-06-08 | 84538 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2021-01-18 | 2021-02-26 | 131875 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2021-05-25 | 2021-10-05 | 139845 |
| APO-LEVETIRACETAM | 500MG | TABLET | Resolved | 2021-08-27 | 2021-10-01 | 144659 |
| APO-LEVETIRACETAM | 500MG | TABLET | Resolved | 2022-06-27 | 2022-08-24 | 163448 |
| APO-LEVETIRACETAM | 250MG | TABLET | Resolved | 2022-07-15 | 2022-08-24 | 164710 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2022-08-19 | 2022-08-24 | 167416 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2022-11-20 | 2022-12-23 | 175321 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-02-02 | 2023-06-23 | 183477 |
| APO-LEVETIRACETAM | 250MG | TABLET | Resolved | 2023-04-14 | 2023-06-23 | 189641 |
| APO-LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-09-07 | 2023-10-27 | 203840 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-09-15 | 2023-10-27 | 204405 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2023-11-17 | 2023-12-15 | 210656 |
| APO-LEVETIRACETAM | 500MG | TABLET | Resolved | 2023-12-08 | 2023-12-15 | 212931 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2024-02-02 | 2024-03-15 | 218370 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| APO-PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |